Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Todays Updates


Sanofi Says Rare Lung Disease Drug Outperforms Standard Care in Trial


(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Advance Directives When Suicide Is Involved: Ethicist


Ethicist Art Caplan discusses a recent case involving attempted suicide and advance directives

Spinal Anesthesia for Circumcision Tops General Anesthesia


Spinal anesthesia offers faster recovery, similar OR time, and significantly less opioid use, with no increase in cost or OR delays.

Single Bevacizumab Dose Sustains Trabeculectomy Success


A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.

US States Reject Anti-vaccine Bills as Public Health Groups Fight MAHA


Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...

US Health Department Withdraws Vaccine Advisory Panel Charter


The U.S. health department has withdrawn an April charter renewal for a key vaccine ⁠advisory panel that laid out new membership rules and direction, citing an...

Britain Gets Experimental Drug From Japan to Bolster Hantavirus Response


Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus ⁠outbreak linked to the Hondius cruise liner, the...

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Measurable Residual Disease Predicts Real-World AML Relapse

2.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

3.

For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.

4.

FDA Expands Approval of Osimertinib in Lung Cancer

5.

Effective Intralesional Melanoma Therapy May Involve Systemic Effects.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot